Published • loading... • Updated
ByteDance Spins Off AI Drug Discovery Business for Independent Financing, AI4S Enters Industrial Phase
Summary by Pandaily
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ByteDance Spins Off AI Drug Discovery Business for Independent Financing, AI4S Enters Industrial Phase
ByteDance is spinning off its AI drug discovery business into a separate entity and initiating an independent financing process, marking a major step toward commercializing its artificial intelligence capabilities in life sciences. Following the spin-off, ByteDance will retain majority control of the new company. The core AI drug discovery team, comprising approximately 50 members led by Liu Kai and consisting of AI4S algorithm specialists and s…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
